Abdominal Neoplasms
📧 Sign up to get email alerts when something new happens for Abdominal Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-04EMA Authorised: Vitrakvi (larotrectinib sulfate) — Bayer AG
EMA authorised Vitrakvi (larotrectinib sulfate) for use in abdominal neoplasms under conditional approval.
-
EMA approval · 2026-07-22EMA Authorised: Vitrakvi (larotrectinib sulfate) — Bayer AG
The EMA authorises Vitrakvi (larotrectinib sulfate) from Bayer AG with conditional approval for abdominal neoplasms.
-
EMA approval · 2026-07-14EMA Authorised: Vitrakvi (larotrectinib sulfate) — Bayer AG
EMA has authorised Vitrakvi (larotrectinib sulfate) by Bayer AG with conditional approval for abdominal neoplasms.
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors [Phase 3]
A Phase 3 clinical trial is evaluating pafolacianine as an imaging agent to identify lesions in pediatric patients with primary or metastati…
-
EMA approval · 2026-03-11EMA Authorised: Vitrakvi (larotrectinib sulfate) — Bayer AG
EMA authorised Vitrakvi (larotrectinib sulfate) for abdominal neoplasms with conditional approval; Bayer AG is the marketing authorisation h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy [Phase 2]
Phase 2 trial evaluating oral iohexol for management of chylous ascites after retroperitoneal or extended lymphadenectomy; the study status …
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: KeyScope Study in Uganda [NA]
The KeyScope clinical trial sponsored by Duke University is planned in Uganda for abdominal neoplasms and is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: To Evaluate the Safety and Efficacy of Histotripsy for the Symptom Relief of Inoperable Abdominal Tumors [NA]
Clinical trial updating the safety and efficacy evaluation of histotripsy, a noninvasive ultrasound technique, for symptom relief in patient…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: A Pan-cancer Screening and Diagnosis Model Based on Abdominal CT Was Established
This document reports the establishment of a pan-cancer screening and diagnosis model based on abdominal CT imaging and notes that the trial…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: EUS GUIDED Transduodenal Biopsy Using the 19G Flex [NA]
Completed clinical trial evaluating EUS-guided transduodenal biopsy with a 19G Flex needle for abdominal neoplasms; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2011-09-20Clinical Trial Update: Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors [Phase 1]
A Phase 1 trial at St. Jude Children's Research Hospital determined a safe dose of the ultrasound contrast agent Optison in pediatric patien…
-
CLINICAL_TRIALS trial_result · 2011-07-22Clinical Trial Update: Restricted Intravenous Fluid Regime Effects on Immunological Indicators of Elderly Patients Operated for Abdominal Cancer [Phase 3]
This Phase 3 trial update investigates the effects of a restricted intravenous fluid regime on immunological indicators in elderly patients …
-
CLINICAL_TRIALS trial_result · 2010-04-05Clinical Trial Update: Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer Surgery [Phase 3]
Clinical trial update noting the completion of a Phase 3 Japanese efficacy and safety study of enoxaparin in patients undergoing curative ab…